Molly Frey

431 total citations
14 papers, 311 citations indexed

About

Molly Frey is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Molly Frey has authored 14 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Biomaterials and 3 papers in Biomedical Engineering. Recurrent topics in Molly Frey's work include RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Molly Frey is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Molly Frey collaborates with scholars based in United States, Ecuador and Philippines. Molly Frey's co-authors include Evan A. Scott, Sharan Bobbala, Nicholas B. Karabin, Michael P. Vincent, Yugang Liu, Sean D. Allen, Sijia Yi, Jacqueline A. Burke, Guillermo A. Ameer and Xiaomin Zhang and has published in prestigious journals such as Nature Communications, Nature Nanotechnology and Chemical Communications.

In The Last Decade

Molly Frey

14 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Molly Frey United States	8	110	106	74	71	38	14	311
Mingqian Li China	8	95 0.9×	116 1.1×	101 1.4×	47 0.7×	36 0.9×	24	309
Patrick McMullen United States	11	157 1.4×	112 1.1×	84 1.1×	34 0.5×	18 0.5×	16	345
Zunkai Xu China	10	180 1.6×	139 1.3×	146 2.0×	32 0.5×	20 0.5×	16	391
Julia S. Caserto United States	10	73 0.7×	148 1.4×	186 2.5×	86 1.2×	81 2.1×	11	396
Sunny Kumar United States	2	133 1.2×	128 1.2×	97 1.3×	36 0.5×	35 0.9×	2	373
Morten Frendø Ebbesen Denmark	12	245 2.2×	80 0.8×	44 0.6×	57 0.8×	17 0.4×	24	551
Julie Taillefer Canada	7	79 0.7×	137 1.3×	115 1.6×	48 0.7×	18 0.5×	8	340
Lingjie Ke China	13	105 1.0×	137 1.3×	191 2.6×	44 0.6×	12 0.3×	19	431
Jong Chul Kim South Korea	10	124 1.1×	131 1.2×	97 1.3×	19 0.3×	39 1.0×	12	374
Guangyu Rong China	9	227 2.1×	100 0.9×	111 1.5×	38 0.5×	12 0.3×	16	385

Countries citing papers authored by Molly Frey

Since Specialization

Citations

This map shows the geographic impact of Molly Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Frey more than expected).

Fields of papers citing papers by Molly Frey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Frey. The network helps show where Molly Frey may publish in the future.

Co-authorship network of co-authors of Molly Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Molly Frey. A scholar is included among the top collaborators of Molly Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly Frey. Molly Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Brew, Stefan, Molly Frey, Derrick McCarthy, Adam Elhofy, & Richard J. Nowak. (2024). Antigen-specific immune therapy (CNP-106) for treatment of generalised myasthenia gravis: rationale and design of first-in-human randomised controlled trial. BMJ Neurology Open. 6(2). e000836–e000836. 1 indexed citations

Frey, Molly, et al.. (2023). Risk Factors for the Mental Health of Adolescents from the Parental Perspective: Photo-Voice in Rural Communities of Ecuador. International Journal of Environmental Research and Public Health. 20(3). 2205–2205. 2 indexed citations

Burke, Jacqueline A., Xiaomin Zhang, Sharan Bobbala, et al.. (2022). Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability. Nature Nanotechnology. 17(3). 319–330. 61 indexed citations

Yi, Sijia, Sunyoung Kim, Michael P. Vincent, et al.. (2022). Dendritic Peptide-Conjugated Polymeric Nanovectors for Nontoxic Delivery of Plasmid DNA and Enhanced Non-Viral Transfection of Immune Cells. SSRN Electronic Journal. 1 indexed citations

Liu, Yugang, et al.. (2021). Enhancing subcutaneous injection and target tissue accumulation of nanoparticles via co-administration with macropinocytosis inhibitory nanoparticles (MiNP). Nanoscale Horizons. 6(5). 393–400. 15 indexed citations

Vincent, Michael P., Sharan Bobbala, Nicholas B. Karabin, et al.. (2021). Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets. Nature Communications. 12(1). 97 indexed citations

Vincent, Michael P., Nicholas B. Karabin, Sean D. Allen, et al.. (2021). The Combination of Morphology and Surface Chemistry Defines the Immunological Identity of Nanocarriers in Human Blood. Advanced Therapeutics. 4(8). 25 indexed citations

Burke, Jacqueline A., Xiaoming Zhang, Molly Frey, et al.. (2021). 209.8: Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability. Transplantation. 105(12S1). S17–S17. 4 indexed citations

Frey, Molly, et al.. (2020). Mapping the supramolecular assembly space of poly(sarcosine)-b-poly(propylene sulfide) using a combinatorial copolymer library. Chemical Communications. 56(49). 6644–6647. 7 indexed citations

10.

Yi, Sijia, Nicholas B. Karabin, Jennifer Zhu, et al.. (2020). An Injectable Hydrogel Platform for Sustained Delivery of Anti-inflammatory Nanocarriers and Induction of Regulatory T Cells in Atherosclerosis. Frontiers in Bioengineering and Biotechnology. 8. 542–542. 24 indexed citations

11.

Frey, Molly, et al.. (2020). Employment of targeted nanoparticles for imaging of cellular processes in cardiovascular disease. Current Opinion in Biotechnology. 66. 59–68. 13 indexed citations

12.

Bobbala, Sharan, Sean D. Allen, Sijia Yi, et al.. (2020). Employing bicontinuous-to-micellar transitions in nanostructure morphology for on-demand photo-oxidation responsive cytosolic delivery and off–on cytotoxicity. Nanoscale. 12(9). 5332–5340. 27 indexed citations

13.

Frey, Molly, Sharan Bobbala, Nicholas B. Karabin, & Evan A. Scott. (2018). Influences of Nanocarrier Morphology on Therapeutic Immunomodulation. Nanomedicine. 13(14). 1795–1811. 33 indexed citations

14.

Frey, Molly, et al.. (1989). Jodspeichernde, hormonproduzierende Lebermetastase eines follikulären Schilddrüsenkarzinoms. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 150(4). 489–489. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact